Conferences - Results from #140

Viewing 141-160 of 11879 articles

ASTRO 2024: Validation of a Digital Pathology-Based MMAI Model in Oligometastatic Castration-Sensitive Prostate Cancer, including Patients from the STOMP and ORIOLE Phase II Randomized Trial

ASTRO 2024: Rectal Wall Infiltration with Hyaluronic Acid Based Rectal Spacer Reversal Protocol

ASTRO 2024: Impact of Hyaluronic Acid Rectal Spacer Quality Score and Fischer-Valuck Spacer Symmetry Score on Rectal Dosimetry and Acute and Late Gastrointestinal Toxicity Outcomes – An Australian Experience

ASTRO 2024: SBRT versus Conventional Fractionation EBRT Boost for Unfavorable Intermediate and High-Risk Prostate Cancer. Early Results of PBS phase II randomized trial

ASTRO 2024: Focal MR-Guided HDR Brachytherapy Boost Combined with SBRT for Localized Prostate Cancer

ASTRO 2024: F-SHARP: Initial Results of a Multi-Institutional Phase 1/2 Trial of Focal Dose-Escalated Salvage HDR Brachytherapy for Radiorecurrent Prostate Cancer

ASTRO 2024: EMPIRE-2: Volumetric Changes and Acute Toxicity with 68Ga PSMA versus 18F-Fluciclovine PET/CT Guided Post-Prostatectomy Radiation: Final Analysis of a Randomized Trial

ASTRO 2024: MRI-Guided versus CT-Guided SBRT for Prostate Cancer: 2-Year Outcomes from the MIRAGE Randomized Clinical Trial

ASTRO 2024: Dose Escalated Pelvic Lymph Node IMRT with a Simultaneous Hypofractionated Boost to the Prostate for NCCN Very-High Risk Adenocarcinoma of the Prostate, a Prospective Trial

ASTRO 2024: Emerging Systemic Therapy and Trials for Small Cell Cancer of the Genitourinary Tract

ASTRO 2024: The RAVENS Phase 2 Randomized Trial: Outcomes of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS

ASTRO 2024: Role of Surgery in the Management of Genitourinary Small Cell Tumors

ASTRO 2024: Radiation Therapy for Small Cell Neuroendocrine Tumors of the Genitourinary Tract

ASTRO 2024: Radiation Therapy for Small Cell Bladder Cancers

ASTRO 2024: Pathologic Features of Small Cell Variants of the Genitourinary Tract

ASTRO 2024: Combination of Nivolumab Immunotherapy with Radiation Therapy and Androgen Deprivation Therapy in the Management of Gleason Group 5 Prostate Cancer: Final Analysis of a Phase 2 Trial

ASTRO 2024: Hypofractionated, Dose-Escalated Radiation vs. Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase 3, Prospective, Randomized Controlled Trial

ASTRO 2024: Pembrolizumab Monotherapy Following Tri-Modality Treatment for Selected Patients with Muscle-Invasive Bladder Cancer

ASTRO 2024: Bi-Institutional Safety Analysis of Combining Radiotherapy and Enfortumab Vedotin in Advanced Urothelial Cancer

ASTRO 2024: Natural History after Likely Cure versus Recurrence after ProsTate RadiOtheRapy (RAPTOR): A Pooled Analysis of More than 13000 Patients from 21 Randomized Controlled Trials

3
4
5
6
7
8
9
10
11
12